Your browser doesn't support javascript.
loading
Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer.
Vergote, Ignace; Pérez-Fidalgo, Jose Alejandro; Hamilton, Erika Paige; Valabrega, Giorgio; Van Gorp, Toon; Sehouli, Jalid; Cibula, David; Levy, Tally; Welch, Stephen; Richardson, Debra L; Guerra, Eva M; Scambia, Giovanni; Henry, Stéphanie; Wimberger, Pauline; Miller, David S; Klat, Jaroslav; Martínez-Garcia, Jerónimo; Raspagliesi, Francesco; Pothuri, Bhavana; Romero, Ignacio; Bergamini, Alice; Slomovitz, Brian; Schochter, Fabienne; Høgdall, Estrid; Fariñas-Madrid, Lorena; Monk, Bradley J; Michel, Dayana; Kauffman, Michael G; Shacham, Sharon; Mirza, Mansoor Raza; Makker, Vicky.
Afiliación
  • Vergote I; BGOG, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
  • Pérez-Fidalgo JA; INCLIVA, CIBERONC, GEICO, Hospital Clinico Universitario de Valencia, Spain.
  • Hamilton EP; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN.
  • Valabrega G; MITO and Department of Oncology, University of Torino, Mauriziano Hospital, Turin, Italy.
  • Van Gorp T; BGOG, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
  • Sehouli J; Department of Gynecology, NOGGO, European Competence Center for Ovarian Cancer, Charité Comprehensive Cancer Center, Charité-Berlin University of Medicine, Berlin, Germany.
  • Cibula D; CEEGOG, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
  • Levy T; Gynecologic Oncology Unit, Department of Obstetrics and Gynecology, ISGO, Wolfson Medical Center, Affiliated with Sackler Faculty of Medicine, Tel Aviv University, Holon, Israel.
  • Welch S; London Health Sciences Centre, London, ON, Canada.
  • Richardson DL; Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK.
  • Guerra EM; GEICO, Hospital Universitario Ramon y Cajal, Madrid, Spain.
  • Scambia G; MITO, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Henry S; CHU UCL Namur Site Ste Elisabeth, Service d'onco-hématologie (SORMN), BGOG and Université Catholique de Louvain, Namur, Belgium.
  • Wimberger P; Department of Obstetrics and Gynecology, University Hospital Carl Gustav Carus, NOGGO and Technische Universitat Dresden, Dresden, Germany.
  • Miller DS; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX.
  • Klat J; University Hospital Ostrava and University of Ostrava, Ostrava-Poruba, Czech Republic.
  • Martínez-Garcia J; Department of Oncology, GEICO, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain.
  • Raspagliesi F; Fondazione IRCCS, Istituto Nazionale dei Tumori, Milano, Italy.
  • Pothuri B; NYU Langone Health, Perlmutter Cancer Center, New York University School of Medicine, New York, NY.
  • Romero I; Medical Oncology, Fundacion Instituto Valenciano de Oncologia, Valencia, Spain.
  • Bergamini A; Department of Obstetrics and Gynecology, San Raffaele Milano, Milano, Italy.
  • Slomovitz B; Università Vita-Salute San Raffaele, Milano, Italy.
  • Schochter F; Mount Sinai Medical Center, Florida International University, Miami, FL.
  • Høgdall E; Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
  • Fariñas-Madrid L; Department of Pathology, Herlev Hospital Copenhagen University Hospital, Copenhagen, Denmark.
  • Monk BJ; Gynaecologic Cancer Programme, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Michel D; GOG, HonorHealth, University of Arizona, Creighton University, Phoenix, AZ.
  • Kauffman MG; Karyopharm Therapeutics, Newton, MA.
  • Shacham S; Karyopharm Therapeutics, Newton, MA.
  • Mirza MR; Karyopharm Therapeutics, Newton, MA.
  • Makker V; Rigshospitalet-Copenhagen University Hospital, Copenhagen, Denmark.
J Clin Oncol ; 41(35): 5400-5410, 2023 Dec 10.
Article en En | MEDLINE | ID: mdl-37669480
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Endometriales / Hidrazinas Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Bélgica
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Endometriales / Hidrazinas Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Bélgica